These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 22581736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
    Martinelli M, de Siqueira SF, Sternick EB, Rassi A, Costa R, Ramires JA, Kalil Filho R.
    Am J Cardiol; 2012 Oct 01; 110(7):1040-5. PubMed ID: 22727179
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy.
    Verma A, Sarak B, Kaplan AJ, Oosthuizen R, Beardsall M, Wulffhart Z, Higenbottam J, Khaykin Y.
    Pacing Clin Electrophysiol; 2010 Mar 01; 33(3):320-9. PubMed ID: 19796352
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy.
    Yap SC, Schaer BA, Bhagwandien RE, Kühne M, Dabiri Abkenari L, Osswald S, Szili-Torok T, Sticherling C, Theuns DA.
    Heart; 2014 Aug 01; 100(15):1188-92. PubMed ID: 24993502
    [Abstract] [Full Text] [Related]

  • 10. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy.
    Alsheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes NA, Link MS.
    J Cardiovasc Electrophysiol; 2008 Aug 01; 19(8):784-9. PubMed ID: 18284493
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Appropriate therapies predict long-term mortality in primary and secondary prevention of sudden cardiac death.
    Stabile G, D'Agostino C, Gallo P, Marrazzo N, Iuliano A, De Simone A, Turco P, Palella M, Donnici G, Ciardiello C, Napolitano G, Solimene F.
    J Cardiovasc Med (Hagerstown); 2013 Feb 01; 14(2):110-3. PubMed ID: 22367567
    [Abstract] [Full Text] [Related]

  • 16. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI, Theuns DA, van Dalen BM, Vletter WB, Nemes A, Jordaens LJ, Balk AH, Ten Cate FJ, Geleijnse ML.
    Am J Cardiol; 2010 Jan 01; 105(1):105-11. PubMed ID: 20102900
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up.
    Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Maciag A, Gepner K, Pytkowski M, Kowalik I, Maczyńska-Mazuruk R, Ruzyłło W, Szwed H.
    J Cardiovasc Electrophysiol; 2010 Aug 01; 21(8):883-9. PubMed ID: 20132378
    [Abstract] [Full Text] [Related]

  • 19. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention.
    Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, Dalal D, Tedford R, Russell SD, Abraham T, Tandri H, Judge DP, Calkins H.
    J Am Coll Cardiol; 2011 Sep 27; 58(14):1485-96. PubMed ID: 21939834
    [Abstract] [Full Text] [Related]

  • 20. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L.
    Rev Esp Cardiol; 2006 Jun 27; 59(6):537-44. PubMed ID: 16790196
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.